PUNE, May 28, 2020 (GLOBE NEWSWIRE) -- The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases. Some studies say that psoriasis may further develop other chronic diseases that cause harm to the immune system of the body. These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others. It may also cause polycystic ovarian syndrome and pregnancy complications in women.
A recent report by Fortune Business Insights offers a qualitative and quantitative analysis of this market and its growth parameters. As per this report titled, “Psoriasis Treatment Market Size, Share and Industry Analysis By Drug Class (TNF Inhibitors, Interleukins, Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), and Regional Forecast 2019-2026,” According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026.
Request a Sample Copy of the Research Report: tps://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/psoriasis-treatment-market-100600
The report answers the following Questions:
- What is the nature of the market competition?
- How will major investment in novel development and clinical trials positively impact the psoriasis treatment market?
- Which strategies are acquired by vendors to earn the lion’s share in the market?
- Which are the significant industrial trends of the market?
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
To get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600
Drivers & Restraints-
Increasing Investment on Development of Biologicals for Treatment will Augment Growth
The World Health Organization predicts the frequency of psoriasis to vary from 0.09% to 11.0% throughout all nations, thereby making it a serious problem worldwide. The increasing prevalence of this disease is a major psoriasis treatment market growth driver. Besides this, the advent of novel biologicals for treating various diseases is also expected to add impetus to the market. Product development, clinical trials, and innovation to cure this non-communicable disease are expected to bode well for the market.
On the negative side, the lack of consensus for treatment outcomes, expensive products, and delays in diagnostic procedures may cause major hindrance to the market in the forecast years. This, coupled with the delays associated with clinical management may also hamper the overall market size.
Nevertheless, heavy investments in research and development for treating psoriasis and a rise in penetration of innovative products will create better growth opportunities in the near future.
Segment-
TNF Inhibitors Segment to be Overpowered in Forecast Years Due to Declining Prices of Branded Products
Based on segmentation by drug class, the TNF inhibitors segment was dominating the market in the past. In 2018, this segment earned a 46.3% psoriasis treatment market share. However, the advent of biosimilar and increasing prescription volume for interleukin inhibitors resulted in a decline in the rate of branded products. Owing to the factor stated above, the interleukin inhibitors segment is likely to overpower the TNF inhibitors segment in the coming years.
Regional Analysis-
North America to Dominate Market on Account of Presence of Strong Healthcare Facilities
The National Psoriasis Foundation states an estimate of 8 million Americans who are suffering from psoriasis. The increasing number of people suffering from this disease in America and Canada is responsible for the dominance of the North American market. Besides this, the presence of strong healthcare facilities, the adoption of biological therapies at a high rate, and the heavy investments in research and development, and clinical trials are also boosting the regional market.
Europe emerged as the second largest market and Asia Pacific is likely to register faster growth rates in the coming years on account of the rise in geriatric population, improving healthcare and medical facilities, and the adoption of high tech medical equipment for various diagnostic procedures.
Quick Buy - Psoriasis Treatment Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100600
Competitive Landscape-
FDA Approvals for Clinical Trails – Key Objective of Players
Companies are engaging in clinical trials, research and development, and other innovative ideas and massively investing in the same to make their mark in the competition. They are also focused on gaining clinical approvals from the Food and Drug Administration (FDA) which will further add more revenue to the market.
Major Industry Developments of the Psoriasis Treatment Market include:
February 2019 – FDA approved the use of TREMFYA, an injector that can be controlled by the patient single-handedly by Janssen Pharmaceuticals, a part of Johnson & Johnson Services Inc., for treating both severe and moderate cases of Psoriasis.
April 2019 – Duobrii the first and only lotion for adults suffering from psoriasis manufactured by Ortho Dermatologics received FDA approval.
Fortune Business Insights™ lists out the names of players operating in the Psoriasis Treatment Market. They are as follows:
- Amgen Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Eli Lilly and Company
- UCB S.A.
- Novartis AG
- LEO Pharma A/S
- CELGENE CORPORATION
- AbbVie Inc.
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Other players
Have Any Query? Ask Our Experts: ttps://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/psoriasis-treatment-market-100600
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Psoriasis and Psoriatic Arthritis for Key Countries/Region
- Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
- Pipeline Analysis for Key Companies
- Regulatory Framework by Key Countries
- Global Reimbursement Scenario
- Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- TNF Inhibitors
- Interleukins
- Others
- Market Analysis, Insights and Forecast – By Type
- Plaque Psoriasis
- Psoriatic Arthritis
- Others
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Parenteral
- Topical
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia pacific
- Latin America
- Middle East & Africa
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/psoriasis-treatment-market-100600
Have a Look at Related Reports:
Psoriatic Arthritis Treatment Market Size, Share and Global Trend By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies) and Geography Forecast till 2026
Dermatitis Drugs Market Size, Share and Global Trend Product By Therapy (Chemotherapy, Radiotherapy, Targeted therapy) By Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma) By End User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers) and Geography Forecast to 2025
Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Share and Global Trend By Infection Type (Hospital-acquired ABSSSI, Community-acquired ABSSSI), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026
Aesthetic/Cosmetic Lasers Market Size, Share & Industry Analysis, By Application (Hair Removal, Pigmentation & Tattoo Removal, Body Shaping & Tightening, Skin rejuvenation, Acne Reduction, and Others), By End User (Hospitals and Specialty Clinics) and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/psoriasis-treatment-market-9212